Hepatitis
CDC Report: Viral Hepatitis Rates Decreasing or Remaining Stable
A newly released CDC report demonstrates that five of 10 indicators assessing progress toward viral hepatitis ...
JULY 10, 2025
Increasing The Number of People Protected Against HBV
With the April 2022 recommendation that all U.S. adults between the ages of 19 and 59 years be vaccinated against ...
OCTOBER 6, 2023
Hepatitis D Pipeline Looks Promising
Interim results from a new phase 3 trial support the safety and efficacy of monotherapy with bulevirtide ...
DECEMBER 8, 2021
Phase 3 Data Look Promising for HDV Monotherapy
Interim results from a new phase 3 trial support the safety and efficacy of monotherapy with bulevirtide ...
NOVEMBER 5, 2021
FDA Approves New Formulation of Epclusa; Expands HCV Indication for Children as Young as 3
As of 2018, there were approximately 35,300 to 60,500 U.S. children living with HCV, and the incidence is ...
JUNE 16, 2021
SPs Help Make HCV+ Organ Transplantation Safer
Organ transplants from HCV-positive donors to HCV-negative recipients will continue to increase in frequency as ...
APRIL 8, 2021
Opioid Crisis Also Affects HAV and HBV Rates
Thanks to direct-acting antivirals, hepatitis C virus (HCV) has gotten a lot of attention, but infectious disease ...
OCTOBER 16, 2020
In Prison and Out, Untreated HCV Still Poses Burden
The era of DAA therapy has brought cures for HCV to hundreds of thousands of people. But some populations still are ...
MARCH 27, 2020
FDA Approves Epclusa for Children With Any Strain of HCV
Epclusa is the the first pan-genotypic, protease inhibitor–free regimen indicated for children.
MARCH 25, 2020
HCV-Infected Kidneys Function As Well As Uninfected Organs
Kidneys from donors who were infected with hepatitis C virus (HCV) function as well as uninfected organs throughout ...
OCTOBER 24, 2019
FDA Shortens Mavyret Therapy for Certain Children With HCV
The new treatment course will be indicated for treatment-naive children aged 12 years and older or weighing at ...
SEPTEMBER 27, 2019
U.S. Prevalence of HepD May Be Higher Than Many Realize
Hepatitis D virus is a defective human RNA virus that requires HBsAg for transmission and persistence. Compared ...
SEPTEMBER 18, 2019
